Local levels of active thyroid hormone (3,3′,5-triiodothyronine) are controlled by the action of activating and inactivating iodothyronine deiodinase enzymes. Deiodinases are selenocysteine-dependent membrane proteins catalyzing the reductive elimination of iodide from iodothyronines through a poorly understood mechanism. We solved the crystal structure of the catalytic domain of mouse deiodinase 3 (Dio3), which reveals a close structural similarity to atypical 2-Cys peroxiredoxin(s) (Prx). The structure suggests a route for proton transfer to the substrate during deiodination and a Prx-related mechanism for subsequent recycling of the transiently oxidized enzyme. The proposed mechanism is supported by biochemical experiments and is consistent with the effects of mutations of conserved amino acids on Dio3 activity. Thioredoxin and glutaredoxin reduce the oxidized Dio3 at physiological concentrations, and dimerization appears to activate the enzyme by displacing an autoinhibitory loop from the iodothyronine binding site. Deiodinases apparently evolved from the ubiquitous Prx scaffold, and their structure and catalytic mechanism reconcile a plethora of partly conflicting data reported for these enzymes.
Local levels of active thyroid hormone (3,3′,5-triiodothyronine) are controlled by the action of activating and inactivating iodothyronine deiodinase enzymes. Deiodinases are selenocysteine-dependent membrane proteins catalyzing the reductive elimination of iodide from iodothyronines through a poorly understood mechanism. We solved the crystal structure of the catalytic domain of mouse deiodinase 3 (Dio3), which reveals a close structural similarity to atypical 2-Cys peroxiredoxin(s) (Prx). The structure suggests a route for proton transfer to the substrate during deiodination and a Prx-related mechanism for subsequent recycling of the transiently oxidized enzyme. The proposed mechanism is supported by biochemical experiments and is consistent with the effects of mutations of conserved amino acids on Dio3 activity. Thioredoxin and glutaredoxin reduce the oxidized Dio3 at physiological concentrations, and dimerization appears to activate the enzyme by displacing an autoinhibitory loop from the iodothyronine binding site. Deiodinases apparently evolved from the ubiquitous Prx scaffold, and their structure and catalytic mechanism reconcile a plethora of partly conflicting data reported for these enzymes.
iodothyronine deiodination | thioredoxin fold | selenoprotein | thiol cofactor | selenenyl-sulfide T hyroid hormones regulate mammalian development as well as energy expenditure and metabolism in the adult (1) . The active, nuclear receptor-binding form of thyroid hormone is 3,3′,5-triiodothyronine (T 3 ). The thyroid gland mainly releases thyroxine [3,3′,5 ,5′-tetraiodothyronine (T 4 ); Fig. 1A ], and T 3 is formed and degraded through elimination of iodine atoms from the 5′-and 5-positions, respectively (2) (Fig. S1 ). Three types of deiodinase enzymes are involved in activation and inactivation of thyroid hormones (Fig. S1 ). They form a family of transmembrane enzymes with homologous catalytic domains (2) . Type II deiodinase (Dio2) catalyzes the activating (outer ring) 5′-deiodination of the prohormone T 4 to T 3 , whereas type III deiodinase (Dio3) catalyzes inactivating (inner ring) 5-deiodination (2) . Type I deiodinase (Dio1) is capable of both types of reactions (3) . Cells targeted by the hormone can thereby fine-tune intracellular T 3 levels through deiodinase expression according to their needs during development or upon metabolic challenges. Dio1, Dio2, and Dio3 share a conserved amino acid sequence and a selenocysteine residue essential for efficient deiodination, although nonmammalian cysteine-deiodinases have been found (4, 5) . Although most of the characterized selenoproteins act as peroxidases or protein reductases, deiodinases are the only selenoenzymes known to catalyze halogen eliminations from aromatic rings. Despite a large body of experimental data, there is no coherent model for deiodinase catalysis that incorporates the bulk of available data.
Results and Discussion
To explore the unique deiodinase catalytic mechanism, we determined the crystal structure of the cytoplasmic catalytic domain of Mus musculus Dio3 (Dio3 cat ) with Sec 170 replaced by cysteine ( Fig. 1 B and C and Table 1 ). The structure was solved by selenium single-wavelength anomalous dispersion phasing using crystals of selenomethionine (SeMet)-labeled Dio3 cat . Refinement of native and SeMet-labeled Dio3 cat resulted in structures without recognizable differences, neither for the backbone (rmsd for 186 Cα positions = 0.2 Å) nor for side chains, with slightly better statistics for the SeMet structure (Table 1) . Further analyses were thus done with the SeMet structure refined at a resolution of 1.9 Å to R/R free values of 18.7% and 22.7%, respectively.
Overall Deiodinase Structure and Substrate Binding Site. Dio3 cat adopts a thioredoxin (Trx) fold (6) as previously predicted (7), with deiodinase-specific modifications and insertions, resulting in architecture with a five-stranded, mixed β-sheet flanked by four α-helices ( Fig. 1 B and C) . N-terminal to the Trx βαβ-motif lies a small, two-stranded, antiparallel β-sheet, βN, followed by a short 3 10 -helix, Θ1. The essential deiodinase-specific insertion (Dio-insertion, residues 201-225; Fig. 1 B and C) forms a large loop-D, followed by a helix αD and a short βD that aligns with the central mixed β-sheet. The loop, which is critical for iodothyronine binding and was previously called an iduronidase-like insertion, forms a compact protrusion instead of the predicted Significance Deiodinases activate and inactivate thyroid hormones through a unique biochemical reaction. Enzymes expand their catalytic capabilities through special heteroatoms in cofactors or in the rare but essential amino acid selenocysteine, and deiodinases use an active-site selenocysteine for the reductive elimination of iodide from the aromatic iodothyronine rings. The mechanism of deiodinases has remained elusive despite many mutational and enzymatic studies. We solved the crystal structure of the deiodinase catalytic domain and find that it resembles a family of peroxiredoxin(s) (Prx). Structure and biochemical data suggest a deiodinase catalytic mechanism with Prx-like elements and enable us to assign unexpected functions to residues previously reported to contribute to deiodinase catalysis. Our findings indicate how deiodinases may have evolved from a common reductase ancestor.
α-helix (7). The catalytic Sec 170 (replaced by a cysteine in our construct, as indicated by *) is positioned in the loop connecting β1 to α1, in the same position as the peroxidatic cysteine of thiol reductases with a Trx-like fold [Trx, peroxiredoxins (Prx), and glutathione (GSH) peroxidases GPX (see below); Fig. 1D ) is buried between loop-D and helix αD and appears to contribute to catalysis through an interaction with the conserved Glu 200 (see below).
Dio3-His

202
, which corresponds to the catalytically essential Dio1-His
158
, protrudes from the Dio-insertion into the substrate binding cleft (Fig. 1D) . Its distance to the catalytic selenocysteine and position at the end of this cleft suggest that rather than acting catalytically, His 202 serves as a binding partner for the 4′-phenolic end of the substrate, similar to His 435 in the T 3 -receptor β (T 3 Rβ) complex (9) . Superimposing the His ; I is the intensity of an individual measurement, and hIi is the corresponding mean value. § R-factor = P jjFobs j − kjFcalc jj P jFobs j
; jF obs j is the observed structure factor amplitude, and jF calc j is the calculated structure factor amplitude. { R free was calculated from 5% of measured reflections omitted from refinement.
compatible with molecular orbital calculations for 5-deiodination through selenenyl-iodide formation (see below) (10) . The carboxyl group of the substrate is positioned close to the guanidinium group of Dio3-Arg 275 situated in the β4/α3-connecting loop (Fig. 1E ). In line with this T 3 R-like substrate pinching by a histidine-arginine clamp (9), which was also proposed for the T 3 transporter monocarboxylate transporter 8 (11), 5-deiodinase activity is sharply reduced in a Dio3-Arg275Ala mutant (Fig. 1F) . Moreover, Dio3-Glu 259 would be properly positioned for recognizing the iodothyronine amino group. Mutating the corresponding Glu 214 in Dio1 increased the substrate K m , supporting such a role in iodothyronine binding (7).
Deiodinase Dimerization. Deiodinase activity is reported to require dimerization partly mediated by the catalytic domain but critically depending on the N-terminal transmembrane anchor and linker region (12) . Indeed, full-length Dio3 formed dimers ( Fig.  2A) , whereas our N-terminally truncated recombinant Dio3 cat protein behaved as a monomer in gel filtration and mainly monomeric, with little dimeric species, in native gel electrophoresis (Fig. 2B) . The catalytic domain itself thus has weak dimerization capabilities but requires support by the N-terminal region to form stable dimers. All protein/protein interactions observed in the Dio3 cat crystal structure appear to represent crystal contacts, and the structure thus constitutes an inactive monomeric form. In this inactive state, Phe 258 from the α2/β3-loop protrudes into the substrate-binding cleft around Sec 170 and blocks the active site ( Fig. 2C) . Consistently, soaking Dio3 cat crystals with iodothyronine substrate or with the inhibitor iopanoic acid did not result in electron density for a ligand. Phe 258 is the only Dio3 cat residue in the disallowed region of the Ramachandran plot, yet it is well defined by electron density. The α2/β3-loop, known to contribute to substrate binding in other Trx-fold proteins (13), thus appears to assume a strained, autoinhibited conformation. We speculate that the loop is relaxed upon dimerization, allowing access to the binding site and the reactive Sec 170 that is, until then, shielded by Phe 258 . When we limited its conformational flexibility by a Phe258Pro mutation, 5-deiodinase activity was indeed repressed (Fig. 1F) . Likewise, mutation of Tyr 257 to Ala inactivated the enzyme, indicating that its activity is sensitive to changes of the α2/β3-loop sequence (Fig.  1F) . Interestingly, several amino acids conserved across deiodinases and exposed to the surface, but not directly involved in substrate binding or catalysis, cluster around β4 and α3 (Fig.  2D ). This region mediates dimerization in the redoxins hemebinding protein 23 kDa (HBP23) and Populus trichocarpa X deltoids GPX-like peroxidase (PtGPX5), structural homologs of Dio3 cat (see below) (14, 15) . Modeling a Dio3 cat dimer based on an HBP23 template [Protein Data Bank (PDB) ID code 1QQ2; Fig.   2E ] results in close contacts between the N-terminal loop and β4 of one monomer and the β4/α3-loop and substrate site of the second monomer, which may mediate relaxation of the α2/β3-loop, and thus allow substrate binding ( Fig. 2 C and E) . In contrast, the conserved Ile-Tyr-Ile [196] [197] [198] motif previously proposed to mediate dimerization (12) is hidden in the enzyme's hydrophobic core and appears to contribute to Dio3 cat stability and activity (see below).
Proton Transfer During Reductive 5-Deiodination. Our Dio3 structure supports a previously proposed deiodinase half-reaction that leads to the formation of a reduced deiodinated substrate and concomitant formation of an oxidized selenenyl-iodide enzyme intermediate (16) . This deiodination step is supported by density functional theory studies suggesting a selenolate inline attack on the iodine σ-hole weakening the carbon-iodine bond. The abstracted iodonium is replaced by a proton approaching from the opposite side of the ring (10). Our structure suggests that the proton is conveyed to the 5-position of the iodothyronine along a triad His 219 , Glu
200
, and Ser 167 (Fig. 1E) , with residues Tyr 197 and Thr 169 participating in the organization of an intricate H-bond network (Fig. 3A) . This mechanism explains the conservation of Glu 200 and His
219
, as well as previous mutagenesis results on these two residues in Dio1 and Dio2 (7, 8) . In addition, it explains how Glu 200 and His 219 can contribute to catalysis despite their distance to the reacting iodine. To probe the catalytic relevance of Glu 200 and the other network residues, we tested the activities of several Dio3 mutants (Fig. 3B) . Removing the acidic function in Dio3-Glu200Thr inactivated the enzyme completely. The same result was obtained for removing the interacting hydroxyl groups in Tyr197Phe and in Thr169Ala (Fig. 3 A and B) . A Thr169Ser mutant, in contrast, showed only ∼60% reduced activity compared with WT Dio3, consistent with the catalytic relevance of the residue's hydroxyl group and with the best suitability of a threonine in this position indicated by the absolute conservation of Thr 169 in deiodinases. Mutation of Ser 167 , which is also conserved among deiodinases and even in Prx (see below) to Ala decreased activity by >90% (Fig. 3B) . Ser 167 is positioned next to the substrate protonation site and forms the end point of the catalytic H-bond network (Figs. 1D and 3A) . Although the exact catalytic function of this network remains to be clarified, our analyses suggest that it conveys a proton or prepares a water molecule for protonation of the iodothyronine upon deiodination (Fig. 3A) .
Structural Similarity to Prx Proteins. Due to its instability, a selenenyl-iodide intermediate has not been observed in deiodinases and has only recently been detected in a sterically protected model compound (17) . Whether the selenenyl-iodide may hydrolyze in an aqueous environment to form a selenenic acid, in analogy to the sulfenic acid intermediate in Prx (18) , remains to be clarified. In fact, there is no consensus on the mechanism for the entire second deiodinase half-reaction (i.e., iodide release, reduction of the oxidized enzyme). The deiodinase crystal structure now suggests an answer to this question. The Trx superfamily comprises protein families with different functions, characterized by family-specific modifications to the Trx fold (6) .
Comparison of Dio3
cat with known structures reveals close structural similarity to proteins related to atypical 2-Cys Prx, such as the poplar thiol peroxidase (Tpx) PtGPX5 (15) and the Escherichia coli Tpx (19) (Fig. 3 C and D) . A comparison of Dio3 cat and PtGPX5 (PDB ID code 2P5Q) with Prx shows that Dio3 and PtGPX5 differ only in a C-terminally longer α2 and a shorter loop-D in PtGPX5 (Fig. 3C ) and that they indeed feature the two characteristics of the Prx family. An additional helix in the variable Trx-fold insertion, αD in the Dio-insertion, is present in Prx but also in some other Trx-fold protein families (6) . The N-terminal βN1/2-Θ1 module found in Dio3 cat (Fig.  1C) , however, is highly characteristic for Prx. The evolutionary and mechanistic relationship between deiodinase and Prx suggested by these structural characteristics is further supported by a Ser-X-X-Sec motif conserved in all deiodinases. It corresponds to a Ser/Thr-X-X-Cys motif known as a hallmark of all Prx, which comprises the peroxidatic cysteine and a catalytically important Ser/Thr (18, 20) . We find that the corresponding Ser 167 in Dio3 is indeed essential for deiodinase activity (Fig. 3B) . In atypical 2-Cys Prx, a reduced product and an intramolecular disulfide between the peroxidatic cysteine and a resolving cysteine can be formed during the first catalytic half-reaction, and the disulfide is subsequently reduced by Trx. Dio3-Sec 170* superimposes with the peroxidatic Cys 44 in reduced PtGPX5, and Dio3-Cys
239
, which is conserved in all deiodinases, is located in the αD/βD-loop similar to the conserved resolving Cys 92 of PtGPX5 (Fig. 3C ). In the crystal structure of oxidized PtGPX5 (PDB ID code 2P5R), the first turn of α1 and the destabilized αD of the reduced state locally unfold and enable a disulfide bridge between Cys 44 and Cys 92 (15 (Fig. 3D) . We thus propose that Cys 239 may serve as a resolving cysteine in a Prx-like deiodination mechanism with a selenenyl-sulfide as a possible intermediate state.
Prx-Like Deiodinase Reduction Half-Cycle. Oxidized 2-Cys Prx, Tpx, and PtGPX5 are reduced by Trx. In vitro deiodinase assays usually use the nonphysiological reducing agent DTT, but Goswami and Rosenberg (21) purified from cells a protein thiol cofactor resembling glutaredoxin (Grx). Another group identified Trx and Trx reductase (TrxR) as cytosolic factors needed for Dio1 reduction (22) (23) (24) , consistent with decreased Dio1 activity under conditions decreasing reduced Trx (25) . Dio1 activity from liver measured with a physiological NADPH-dependent Trx/TrxR regenerating system was lower than with millimolar DTT but revealed a K m (Trx) of 1.8 μM and a K m [reverse T 3 (rT 3 )] of 1.4 nM, as well as sequential kinetics as in Dio2 and Dio3 (24) . Here, we tested whether physiological regenerating systems containing 3 μM Trx-1 and 0.1 μM Trx receptor 1 or 1 μM Grx-1, 1 mM GSH, and 0.1 μM GSH reductase are capable of sustaining Dio3 activity. Both systems supported Dio3 activity in an NADPH-dependent manner (Fig. 3E) , and the K m (T 4 ) is 6.7 nM in the presence of Trx. GSH alone is able to sustain Dio3 activity but is required in concentrations above 10 mM for significant activity, whereas 1 mM GSH is sufficient in the presence of Grx-1 and the regenerating system (Fig. 3E) . We thus conclude that analogous to Prx, deiodinases can be reduced by the physiological protein thiols Trx-1 and/or Grx-1 coupled to their cognate regenerating systems.
We next analyzed the two cysteines conserved in deiodinases. The putative resolving Cys 239 is conserved even in distantly related nonvertebrate deiodinases (5), whether containing an active-site selenocysteine or cysteine (Fig. S2) . When DTT was used as a reductant, mutation of the Dio1 resolving Cys 194 resulted in decreased V max , which was further decreased when GSH or Trx was used (26) . We generated several Dio3 mutants and tested their activities with our Trx-or Grx-dependent regenerating systems (Fig. 3F) . The activity of Dio3-Cys239Ala appeared unchanged compared with WT. That the peroxidatic residue of a Trx-dependent peroxidase can be directly reduced in the presence of a sufficient thiol partner when the resolving cysteine is mutated is not without precedence (18, 27) . A Trx-dependent Prx from Aeropyrum pernix can be reduced even if the resolving cysteine is removed (28) . For this enzyme, two reduced states were observed, one of them resembling the conformation of its disulfide-bridged, oxidized form (PDB ID code 2CX4), so that reduction of the oxidized peroxidatic residue may take place in the oxidized conformation without prior disulfide formation. Similarly, Trypanosoma brucei PrxII was shown to sample the "disulfide" conformation already in its reduced state and to serve as a substrate for reduction without resolving cysteine and disulfide formation (18, 29) . A cross-link of peroxidatic residue and resolving cysteines is thus proposed to protect the peroxidatic group against overoxidation during the slow reduction cycle rather than to trap the oxidized conformation for reduction (18) . An oxidized conformation in Dio3 with a Sec 170 -Cys 239 selenenyl-sulfide is consistent with selenol-labeling experiments (see below) and with the so far enigmatic results with the Dio1-specific inhibitor propyl-thiouridine (PTU). PTU reacts with Dio1 only after reaction with iodothyronine substrate and competes with the reducing thiol substrate. In the model of oxidized Dio3 (Fig. 3D and Fig. S3 ), Pro 172 would shield the selenenylsulfide from the bulky PTU. Consistently, mutating Pro 172 to the serine found in Dio1 (Ser 128 ) renders Dio3 PTU-sensitive (7).
Potential Deiodinase Isomerization Cascade. In Dio1 and Dio3, a second cysteine is conserved, proximal to the catalytic selenocysteine within a SerCysThrSec motif. Mutating this Cys 124 in Dio1 reduced the V max and increased the K m for DTT 14-fold (26, 30) , leading to the conclusion that the proximal cysteine interacts with the electron donor. Mutation of Dio3-Cys 168 reduced 5-deiodinase activity by 50% in the presence of the Trx/ Grx regenerating systems (Fig. 3F) , and kinetics in presence of GSH indicated a reduction of the V max (Fig. S4) . Deiodination studies with a model compound containing a selenolate and a nearby thiol suggested that a proximal thiol may specifically enhance 5-deiodination (31), which would be consistent with the conservation of this cysteine only in the deiodinases exhibiting inner-ring deiodination, Dio1 and Dio3 (Fig. S2) . We find, however, that a human DIO1-Cys124Ala mutant displays reduced 5′-deiodination activity against rT 3 (Fig. S5) as previously reported (30) , excluding a function specifically in inner-ring deiodination. Instead, we suggest that the proximal cysteine is involved in reduction of Dio3 after initial formation of a Sec 170 -Cys 239 selenenyl-sulfide. Although protected from overoxidation (18) , this state is likely not optimal for reduction. Cys 168 points away from the active site in our structure of reduced Dio3 cat , but it appears properly oriented to attack a Sec 170 -Cys 239 bond in this selenenyl-sulfide form of the enzyme (Fig. 3D) . A reaction of Cys 168 with the selenenyl-sulfide is supported by experiments selectively labeling reduced selenols with the alkylating agent biotin iodoacetamide at low pH (Fig. 3G) . Selectivity for Sec 170 was confirmed by the complete loss of an alkylation signal for the Dio3-Sec170Ala mutant. WT Dio3 was efficiently alkylated after treatment with T 4 substrate in the absence of reducing agent, indicating that the selenenic acid resulting from deiodination can be reduced before interaction with an external reductant. Mutating Cys 239 and/or Cys 168 decreased the selenol labeling (Fig. 3G) , suggesting an intrinsic selenol regeneration mechanism involving both conserved cysteines, the proximal Cys 168 as well as Cys 239 , which is positioned remote from the active site in the reduced enzyme (Fig. 3D) . The requirement of both cysteines suggests a selenenic acid reduction cascade with a 170-239 selenenyl-sulfide isomerizing to a 168-239 disulfide, which might be more accessible for the reducing thiol. Preferential interaction of Trx with a 168-239 disulfide is supported by Dio3 cross-links with a Trx-Cys35Ser variant. WT deiodinase was efficiently crosslinked, but mutation of either Cys 239 or Cys 168 reduced this interaction (Fig. 3H) , suggesting that both cysteines contribute to covalent Trx binding. Overlaying Dio3 cat with a human Trx/Trxreductase complex (PDB ID code 3QFB) (32) indicates Trx binding around the αD C terminus (Fig. S3) , and a 168-239 disulfide appears slightly more accessible from this side (Fig. S6) . The suggested deiodinase mechanism resembles disulfide cascades in Prx carrying three conserved cysteines (28, 33) and is consistent with the observation that mutating the proximal Dio3 cysteine increases the K m for the reducing thiol (26, 30) and/or reduces the overall velocity of the reaction (Fig. 3F) .
Previous results support significant conformational changes during catalysis: Mutation of Dio1-Ser 128 (equivalent position to Dio3-Pro 172 ; Figs. S2 and S3) to proline changes the observed kinetics of Dio1 from ping-pong to sequential (7) . Vice versa, mutation of Pro 135 to Ser changes Dio2 kinetics to ping-pong (7). These findings suggest that this residue modulates the kinetics of local rearrangements at the α1 N terminus required for selenenylsulfide formation. Resolution of the selenenyl-sulfide by a proximal cysteine only in Dio3 and Dio1 would also explain the "molecular memory" in Dio2, which marks the enzyme for ubiquitination after substrate deiodination (34, 35) . The Dio2-specific insertion of 18 amino acids between βN1 and βN2 (destruction sequence) would be in close contact to the part of the enzyme rearranged in the oxidized (selenenyl-sulfide) conformation (Fig. S7) . GSH at concentrations up to 25 mM is unable to reactivate oxidized Dio2 (36) . In contrast, the nonphysiological dithiol DTT apparently can reduce the selenenyl-sulfide, releasing the enzyme for repeated rounds of catalysis in vitro. In fact, mutating Dio2-Ala 131 to cysteine reduced its K m for DTT, supporting the conclusion that a cysteine in this position facilitates the interaction with reducing thiols (36) . In vivo, WT Dio2, without the proximal cysteine, may remain trapped in the 170-239-like selenenyl-sulfide conformation, and is thus marked for degradation.
Conclusions. The crystal structure of Dio3 cat confirms its Trx scaffold and suggests a dimerization interface involved in activation through release of an autoinhibitory loop (Fig. 2C and  Fig. S6 ). Thereby, substrate binding to an arginine/histidine clamp next to the catalytic selenocysteine is enabled. The structure further reveals deiodinase-specific features classifying them as evolutionarily related to atypical 2-Cys Prx. Mutation of the conserved Ser 167 within Dio3's Prx signature motif supports a Prx-like catalytic mechanism. In this mechanism, Sec 170 extracts the 5-iodine as a selenenyl-iodide (16) , which might hydrolyze quickly, and the thyronine ring is protonated via a network of conserved amino acids (Fig. 3A and Fig. S6 ). The oxidized enzyme can be directly reduced by exogenous thiols in vitro. Structural similarity of Dio3 cat to atypical 2-Cys Prx suggests that physiologically, Dio3-Cys 239 acts as a resolving cysteine and can form a selenenyl-sulfide with Sec 170 . Orientation of Cys 168 , the additional conserved cysteine in Dio1 and Dio3, and biochemical data suggest that it can further resolve the selenenyl-sulfide to a Cys 168 -Cys 239 disulfide that is more exposed and reduced more easily by protein thiols. The experimental deiodinase structure thus explains many hitherto enigmatic features of deiodinase biochemistry. The close relationship to Prx-like proteins further suggests an evolutionary pathway explaining how the activity of iodothyronine deiodinase has arisen, with a Prx as an ancestor.
Materials and Methods
Detailed experimental information is provided in SI Materials and Methods.
Structure Solution and Homology Modeling. The active-site selenocysteine of mouse Dio3 was mutated to cysteine, and truncated Dio3 (Dio3 cat , residues 120-304) was cloned in pET151 TOPO for expression in E. coli Rosetta2 cells, followed by nickel-nitrilotriacetic acid affinity chromatography, tobacco etch virus protease digestion, and gel filtration. SeMet-labeled protein was expressed in SeMet medium (Molecular Dimensions) using E. coli strain B834 (DE3). Dio3 cat crystals were set up at 20°C with 20% (wt/vol) PEG 3350 and 0.2 M ammonium citrate (pH 7) as a reservoir solution. Diffraction datasets were collected at 100 K at Swiss Light Source beamline X10SA for native Dio3 cat and at European Synchrotron Radiation Facility ID14-4 for crystals of the SeMetlabeled protein. Indexing, scaling, and merging were done with HKL2000 (37) and XDS (38) for native and SeMet crystals, respectively ( Table 1 ). The structure of Dio3 cat was solved by selenium single anomalous diffraction phasing using SHELXC, SHELXD, and SHELXE (39, 40) and refined using COOT (41) and REFMAC (42) . The structures were analyzed with Procheck (43) . Deiodinase homology models were generated using Modeler (44) . Oxidized Dio3 cat was modeled with oxidized PtGPx5 (PDB ID code 2P5Q) as a template. The Dio3 dimer was generated superimposing Dio3 on a Prx dimer (PDB ID code 1QQ2). For the full-length dimer model, the N-terminal transmembrane and linker part was generated with Phyre2 (45) . To model a Dio3/Trx complex, Dio3 was positioned on top of Trx reductase of a Trx/Trx reductase complex (PDB ID code 3QFB) (32) using secondary structure matching in COOT (41) .
Blue-Native PAGE, Deiodinase Expression in COS-7 Cells, and Deiodinase Activity Assay. The protocol of Schägger et al. (46) was used for bluenative PAGE. Expression plasmids carrying WT and mutant mouse Dio3 cDNAs in pcDNA3 (Invitrogen) were transiently transfected in triplicate or stably transfected into COS-7 cells. The activity of 5-deiodinase was determined using a nonradioactive LC-tandem MS-based assay with direct determination of rT 3 in relation to an internal 13 C-rT 3 standard (47).
